Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Dashboard
Sign Out
Sign In
Register
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Analytics
Research
CDMO
CRO
Excipients
Pharmaceutical Equipment
Pharmaceutical Intermediates
Supply Chain Logistics
Magazine
Current Issue
Archive
Community
Company A to Z
Content Filter
More+
Staffing
Media Kit
Membership Levels
By The Numbers
Press Releases
2189 Articles Available
1
92
Can't find what you're looking for? Try our
advanced search
.
Clinical Results
ACADIA Pharmaceuticals Presents Positive Top-line Results from Dementia-Related Psychosis Trial
PR-M12-19-NI-012
Diagnostics
Takeda and Enzyre to Develop Diagnostic Device Allowing Hemophilia Patients to Determine their Coagulation Status at Home
PR-M12-19-NI-009
Funding
Akoya Biosciences Raises $50 Million in New Financing
PR-M12-19-NI-010
Vaccine
Gavi Board Approves New Ebola Vaccine Program
PR-M12-19-NI-011
Capacity Expansion
PCI Unveils Expanded Clinical Center in Midwest
PR-M12-19-NI-006
Collaboration
Piramal Pharma Solutions Announces Collaboration with BerGenBio on the Development of FDA Fast Track Designated Leukemia Treatment
PR-M12-19-NI-005
R&D Facility
Horizon Therapeutics plc Opens New Manufacturing and R&D Facility in South San Francisco
PR-M12-19-NI-008
Drug Delivery
LEO Pharma and Portal Instruments Announce Collaboration to Develop Needle-Free Drug Delivery Device
PR-M12-19-NI-007
Leadership
Science 37 Names David Coman Chief Executive Officer
PR-M12-19-NI-004
Bristol-Myers Squibb Announces Update for Patients with Resected High-Risk Melanoma and PD-L1 <1%
Business
Merz Forms Fully Focused Global Medical Aesthetics Business: Merz Aesthetics
PR-M12-19-NI-003
FDA Approval
FDA Approves First Treatment for Inherited Rare Disease
PR-M12-19-NI-001
Drug Approval
Calquence Approved in the US for Adult Patients with Chronic Lymphocytic Leukemia
PR-M11-19-NI-037
Facility
HALIX Celebrates Grand Opening of its State-of-the-Art cGMP Facility
PR-M11-19-NI-036
Government
Nation’s Business Groups Call for Full Repeal of Medical Device Tax
PR-M11-19-NI-035
AI
Zebra Medical Vision Joins Forces with Nuance to Bring More AI to Diagnostic Imaging
PR-M11-19-NI-034
FDA Approval
Medtronic Drug-Coated Balloon Receives U.S. FDA Approval to Treat Arteriovenous Fistula Lesions
PR-M11-19-NI-033
Gene Therapy
Ferring and Blackstone Life Sciences Invest Over $570 Million USD in Novel Gene Therapy for Bladder Cancer Patients
PR-M11-19-NI-032
M&A
Novartis to Acquire The Medicines Company for $9.7 Billion
PR-M11-19-NI-031
Partnership
Asuragen Partners with Wave Life Sciences to Develop Companion Diagnostics for Huntington’s Disease
PR-M11-19-NI-030
Investment
Lilly Announces $400 Million Capital Investment in Manufacturing Facilities in Indianapolis
PR-M11-19-NI-028
Leadership
Kronos Bio Appoints Biopharma Industry Veteran Jorge F. DiMartino, M.D., Ph.D., as Chief Medical Officer
PR-M11-19-NI-029
Series B Funding
TISSIUM Closes €39M Series B Funding Round
PR-M11-19-NI-026
Funding
GHO Capital Raises €975m in Largest Ever European Healthcare Fund
PR-M11-19-NI-025
1
92
»
